Evofem's Hormone-Free Contraceptive PHEXXI Seeks UAE Approval

Evofem Biosciences announced that Pharma 1 Drug Store LLC has filed an application with the UAE Ministry of Health and Prevention seeking approval for the commercialization of PHEXXI, Evofem's FDA-approved hormone-free contraceptive. Market research indicates growing demand for hormone-free, on-demand contraception in the UAE and surrounding region. Evofem plans to launch PHEXXI in the UAE as quickly as possible following approval.

Title: Pharma 1 Submits PHEXXI Marketing Application in the UAE

Evofem Biosciences, Inc. (OTCPK: EVFM) announced that Pharma 1 Drug Store LLC has filed an application with the United Arab Emirates (UAE) Ministry of Health and Prevention (MOHAP) seeking approval for the commercialization of PHEXXI, Evofem's FDA-approved hormone-free contraceptive [1]. The application marks a significant milestone in Evofem's global expansion strategy.

PHEXXI, the first and only locally-acting contraceptive gel approved by the U.S. Food and Drug Administration (FDA), is applied zero-to-60 minutes before intercourse using a pre-filled applicator. It works by maintaining the normal vaginal microbiome with a pH inhospitable to sperm and certain pathogens [1].

Market research indicates growing demand for hormone-free, on-demand contraception in the UAE and the surrounding region. Pharma 1 plans to launch PHEXXI in the UAE in the first quarter of 2026, following regulatory approval [2]. Pharma 1 holds exclusive commercialization rights for PHEXXI in the Middle East, including the UAE, Kuwait, Saudi Arabia, Qatar, and certain other countries in the licensed region [1].

Evofem CEO Saundra Pelletier expressed optimism about the potential for PHEXXI in the UAE market, stating, "We look forward to expanding and diversifying our revenue stream with PHEXXI sales to Pharma 1 for the UAE beginning in July 2025..." [2].

Pharma 1 is responsible for obtaining and maintaining any regulatory approvals required to market and sell PHEXXI, and will handle all aspects of distribution, sales, and marketing in these countries [1].

References:
[1] https://www.prnewswire.com/news-releases/evofems-phexxi-submitted-for-marketing-approval-in-united-arab-emirates-by-pharma-1-drug-store-302487645.html
[2] https://www.nasdaq.com/articles/evofem-biosciences-says-pharma-1-applies-marketing-approval-phexxi-uae